The Baruch S. Blumberg Institute

Recognized as one of the world’s leading nonprofit research organizations dedicated to hepatitis B and liver cancer, the Baruch S. Blumberg Institute was established to improve the quality of life for those affected by chronic hepatitis B.


Formerly the Institute for Hepatitis and Virus Research, the Baruch S. Blumberg Institute was cofounded by Dr. Baruch Blumberg, who was responsible for identifying the hepatitis B virus and creating the first vaccine to prevent infection with the virus. Dr. Blumberg was awarded the 1976 Nobel Prize in Medicine for his hepatitis B work.


The Blumberg Institute supports programs dedicated to drug discovery, biomarker discovery and translational biotechnology around common research themes such as chronic hepatitis, liver disease, and liver cancer. It has the largest concentration of nonprofit scientists working on the problem of hepatitis B and liver cancer in the United States. The research being conducted by the Blumberg Institute’s research faculty is internationally recognized as some of the most exciting and promising.


We are proud to partner with the Blumberg Institute and together to be working towards developing a cure for hepatitis B. To learn more, visit